Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

The Safety and Efficacy of SYD-101 in Children With Myopia

ClinicalTrials.gov ID: NCT03918915

Public ClinicalTrials.gov record NCT03918915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 7:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-masked, Vehicle-controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children

Study identification

NCT ID
NCT03918915
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sydnexis, Inc.
Industry
Enrollment
852 participants

Conditions and interventions

Interventions

  • SYD-101 0.01% Drug
  • SYD-101 0.03% Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
3 Years to 14 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 23, 2019
Primary completion
May 1, 2024
Completion
Apr 30, 2025
Last update posted
Jan 14, 2026

2019 – 2025

United States locations

U.S. sites
41
U.S. states
22
U.S. cities
38
Facility City State ZIP Site status
Site 143 Irwindale California 91706
Site 144 Pasadena California 91105
Site 148 San Diego California 92127
Site 104 San Diego California 92131
Site 110 Santa Barbara California 93110
Site 133 Sunnyvale California 94087
Site 130 Colorado Springs Colorado 80920
Site 100 Fort Collins Colorado 80528
Site 102 Danbury Connecticut 06810
Site 150 Waterbury Connecticut 06708
Site 122 Fort Lauderdale Florida 33309
Site 109 Jupiter Florida 33477
Site 119 Sweetwater Florida 33182
Site 120 Tamarac Florida 33321
Site 124 Marietta Georgia 30060
Site 116 Chicago Illinois 60616
Site 106 Wilmette Illinois 60091
Site 135 Indianapolis Indiana 46202
Site 131 Munster Indiana 46321
Site 137 Pittsburg Kansas 66762
Site 138 Bangor Maine 04401
Site 123 Boston Massachusetts 02111
Site 114 Washington Missouri 63090
Site 132 Henderson Nevada 89052
Site 139 Albuquerque New Mexico 87109
Site 127 Buffalo New York 14209
Site 117 Chapel Hill North Carolina 27517
Site 121 Raleigh North Carolina 27603
Site 105 Fargo North Dakota 58103
Site 111 Medford Oregon 97504
Site 147 Tigard Oregon 97223
Sie 136 Bala-Cynwyd Pennsylvania 19004-1108
Site 128 Cranberry Township Pennsylvania 16066
Site 108 Charleston South Carolina 29425
Site 126 Lakeway Texas 78734
Site 142 San Antonio Texas 78215
Site 101 San Antonio Texas 78240
Site 115 The Woodlands Texas 77380
Site 149 Ogden Utah 84403
Site 140 Ogden Utah 84405
Site 113 Virginia Beach Virginia 23452

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03918915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 14, 2026 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03918915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →